Related Experiment Video

Updated: Aug 21, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

[Cardiac resynchronization therapy for heart failure]

Augusto Achilli1, Nicolino Patruno, Daniele Pontillo

  • 1UTIC e U.O.D. di Elettrofisiologia, Ospedale Belcolle, Viterbo.

Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|October 9, 2004
PubMed

Insights

Cardiac resynchronization therapy improves heart failure symptoms and function in many patients. However, identifying non-responders remains a challenge, with new imaging techniques showing promise.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Advanced refractory heart failure has a poor prognosis, linked to left ventricular dysfunction.
  • Conduction delays affect nearly 50% of heart failure patients, impacting cardiac performance.
  • Correcting electrical abnormalities offers a potential therapeutic avenue.

Purpose of the Study:

  • To evaluate the efficacy of biventricular stimulation (cardiac resynchronization therapy) in heart failure patients.
  • To identify factors influencing response to cardiac resynchronization therapy.
  • To explore methods for reducing non-responder rates in cardiac resynchronization therapy.

Main Methods:

  • Biventricular stimulation (cardiac resynchronization therapy) to correct mechanical asynchrony.
  • Analysis of clinical trial data for patients with NYHA class III-IV heart failure, specific QRS duration, LV end-diastolic diameter, and ejection fraction.
  • Utilizing Tissue Doppler imaging to assess left ventricular dyssynchrony in ongoing studies.

Main Results:

  • Biventricular pacing significantly improved left ventricular performance, quality of life, and NYHA class.
  • No significant impact on total mortality was observed in completed trials.
  • Approximately 20-30% of patients were identified as non-responders in prior studies.

Conclusions:

  • Cardiac resynchronization therapy is a valuable treatment for selected heart failure patients, improving key functional parameters.
  • The identification and management of non-responders is a critical area for further research.
  • Tissue Doppler imaging may help personalize therapy and reduce the percentage of non-responders.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...